Hypersensitivity syndrome due to 2 anticonvulsant drugs

Contact Dermatitis

Volumn 41, Issue 3, 1999, Pages 141-144

  Conilleau, V ^b   Dompmartin, A ^b   Verneuil, L ^b   Michel, M ^b   Leroy, D ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Adverse drug reaction; Anticonvulsants; Epilepsy; Ethosuximide; Human herpesvirus 6; Hypersensitivity syndrome; Positive patch test; Sodium valproate

Indexed keywords

CORTISONE; ETHOSUXIMIDE; VALPROIC ACID;

ANTIBODY TITER; ARTICLE; CASE REPORT; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EOSINOPHILIA; EPILEPSY; FEVER; HEPATITIS; HERPES; HUMAN; HUMAN HERPESVIRUS 6; LYMPHOCYTOSIS; MALE; PATCH TEST; PRESCHOOL CHILD;

ANTIBODIES, VIRAL; ANTICONVULSANTS; CHILD; DRUG HYPERSENSITIVITY; ETHOSUXIMIDE; HERPESVIRUS 6, HUMAN; HUMANS; MALE; PATCH TESTS; SYNDROME; VALPROIC ACID;

EID: 0032838076     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0536.1999.tb06105.x     Document Type: Article

References (18)

1. 1. Shear N H, Spielberg S P. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988: 82: 1826-1832.
2. 2. Alldredge B K, Knutsen A P, Ferriero D. Antiepileptic drug hypersensitivity syndrome: In vitvo and clinical observations. Pediatr Neurol 1994; 10: 169-171.
3. 3. Vittorio C C, Muglia J J. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995: 155: 2285-2290.
4. 4. Sotolongo R P, Neele L I, Rudzki C, Ishak K G. Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity. Gastroenterology 1978: 75: 95-99.
5. 5. Bocquet H, Bourgault-Villada I, Delfau-Larue M H, Wechsler J, Revuz J, Roujeau J C. Syndrome d'hypersensibilité à la dapsone. Clone T circulant transitoire. Ann Dermatol Venereol 1995: 122: 514-516.
6. 6. Knowles S R, Shapiro L. Shear N H. Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature. Arch Dermatol 1996: 132: 934-939.
7. 7. Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, Hashimoto K. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998: 134: 1113-1117.
8. 8. Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, Saraux J L, Grange M J, Grossin M, Navratil E, Crickx B, Belaich S. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997: 137: 605-608.
9. 9. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998: 134: 1108-1112.
10. 10. Egger J, Brett E M. Effects of sodium valproate in 100 children with special reference to weight. Br Med J 1981: 283: 577-581.
11. 11. Nabi G. Exfoliative dermatitis (sodium valproate induced). Ann Saudi Med 1993: 13: 388-389.
12. 12. Li L M, Russo M, O'Donhoghue M F, Duncan J S, Sander J W A S. Allergic skin rash with lamotrigine and concomitant valproate therapy. Arq Neuropsiquiatr 1996: 54: 47-49.
13. 13. Plantin P, Cartier H, Le Bihan G, Clouard P, Lellouche F, Leroy JP. Syndrome d'hypersensibilité médicamenteuse au cours d'un traitement par acide valproïque. La Presse Med 1995: 24: 1624.
14. 14. Dreifuss F E, Langer D H. Hepatic considerations in the use of antiepileptic drugs. Epilepsia 1987: 28: S23-S29.
15. 15. Pisani F, Narbone M C, Trunfio C, Fazio A, La Rosa G, Oteri G, Di Perri R. Valproic acid-ethosuximide interaction: a pharmacokinetic study. Epilepsia 1984: 25: 229-233.
16. 16. Mosquera M R, Iglesias A, Saez A, Vidal C. Patch test diagnosis of carbamazepine sensitivity? Contact Dermatitis 1991: 25: 137-138.
17. 17. Calkin J M, Maibach H I. Delayed hypersensitivity drug reactions diagnosed by patch testing. Contact Dermatitis 1993: 29: 223-233.
18. 18. Vaillant L, Camenen I, Lorette G. Patch testing with carbamazepine: reinduction of an exfoliative dermatitis. Arch Dermatol 1989: 125: 299.